Industry Funding of Cancer Patient Advocacy Organizations (Mayo/Medscape)

Medscape
  November 16, 2016

In the new analysis, 51 of the 68 PAOs (75.0%) disclosed their sponsors. Sixteen PAOs (23.5%) did not report whether they had biopharmaceutical sponsorship. The fact that nearly 25% of the PAOs were lacking sponsor disclosures is problematic, say the authors.
"This study may underestimate sponsorship because 23.5% of the PAOs neither acknowledged funding nor a policy precluding it," they write.

  Their new study was published in the November issue of the Mayo Clinic Proceedings.
 Article Outline

1. Methods
2. Results
3. Conclusion
4. References

 Only one of the POAs, the Inflammatory Breast Cancer Research Foundation, explicitly reported that it does not accept money from drug companies.

 Table. PAOs by Cancer Subtypes (Recommended by NCCN)